<DOC>
	<DOCNO>NCT00367445</DOCNO>
	<brief_summary>To compare short-term efficacy safety Exubera v Lantus patient type 2 diabetes mellitus</brief_summary>
	<brief_title>A Clinical Trial Comparing Short-Term Efficacy Safety Exubera Lantus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Diabetes mellitus Type 2 Severe Asthma , severe COPD Smoking</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
</DOC>